This inventor holds 1 USPTO granted patent. Top assignee: Mayo Foundation for Medical Education and Research. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Jenna Corrinne Podjasek: Innovator in Medical Treatment
Introduction
Jenna Corrinne Podjasek is a notable inventor based in Orland Park, IL (US). She has made significant contributions to the field of medical treatment, particularly in the area of anti-type 2 therapy. Her innovative work has the potential to improve the lives of many individuals suffering from various medical conditions.
Latest Patents
Jenna holds 1 patent for her invention titled "Methods for treating medical conditions by anti-type 2 therapy." This patent outlines methods and materials involved in treating medical conditions, specifically focusing on the use of anti-Interleukin 4, anti-Interleukin 5, and/or anti-Interleukin 13 antibodies. These methods are designed to treat asthma in mammals identified as having a Th2 immune response, utilizing a whole blood cell-based cytokine assay.
Career Highlights
Jenna is currently associated with the Mayo Foundation for Medical Education and Research, where she continues to advance her research and innovations in medical treatments. Her work is characterized by a commitment to improving therapeutic approaches for patients.
Collaborations
Jenna has collaborated with esteemed colleagues, including Young J Juhn and Hirohito Kita, to further her research and enhance the impact of her inventions.
Conclusion
Jenna Corrinne Podjasek is a pioneering inventor whose work in anti-type 2 therapy represents a significant advancement in medical treatment. Her contributions are poised to make a lasting impact on the healthcare field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile